197 related articles for article (PubMed ID: 31185171)
1. Elucidation and Structural Modeling of CD71 as a Molecular Target for Cell-Specific Aptamer Binding.
Wu X; Liu H; Han D; Peng B; Zhang H; Zhang L; Li J; Liu J; Cui C; Fang S; Li M; Ye M; Tan W
J Am Chem Soc; 2019 Jul; 141(27):10760-10769. PubMed ID: 31185171
[TBL] [Abstract][Full Text] [Related]
2. CD71-Specific Aptamer Conjugated with Monomethyl Auristatin E for the Treatment of Uveal Melanoma.
Zhang H; Jin C; Zhang L; Peng B; Zhang Y; Liu Y; Li L; Ye M; Xiong W; Tan W
ACS Appl Mater Interfaces; 2022 Jan; 14(1):32-40. PubMed ID: 34928139
[TBL] [Abstract][Full Text] [Related]
3. Record Resolution of Nanometal Surface Energy Transfer Optical Nanoruler Projects 3D Spatial Configuration of Aptamers on a Living Cell Membrane.
Zhang Y; Fang X; Huang W; Li Q; Hu F; Liu H
Nano Lett; 2023 Dec; 23(24):11968-11974. PubMed ID: 38059895
[TBL] [Abstract][Full Text] [Related]
4. Plasmon Resonance Energy Transfer Nanoruler for Pinpointing Molecular Distance and Interaction on the Living Cell Membrane.
Zhang Y; Fang X; Huang W; Li Q; Jiang H; Wang C; Liu H
Nano Lett; 2023 Aug; 23(16):7750-7757. PubMed ID: 37387534
[TBL] [Abstract][Full Text] [Related]
5. Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers.
Yang Q; Peng Y; Deng Z; Zhang D; Long CY; Zhang GR; Li J; Wang XQ; Tan W
Natl Sci Rev; 2023 Aug; 10(8):nwad113. PubMed ID: 37731726
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Transferrin Receptor-1 (CD71) Expression in Acute Lymphoblastic Leukemia.
Hagag AA; Badraia IM; Abdelmageed MM; Hablas NM; Hazzaa SME; Nosair NA
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):610-617. PubMed ID: 29875008
[TBL] [Abstract][Full Text] [Related]
7. DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition.
Wu X; Zhao Z; Bai H; Fu T; Yang C; Hu X; Liu Q; Champanhac C; Teng IT; Ye M; Tan W
Theranostics; 2015; 5(9):985-94. PubMed ID: 26155314
[TBL] [Abstract][Full Text] [Related]
8. Selection and identification of transferrin receptor-specific peptides as recognition probes for cancer cells.
Tan Y; Liu W; Zhu Z; Lang L; Wang J; Huang M; Zhang M; Yang C
Anal Bioanal Chem; 2018 Jan; 410(3):1071-1077. PubMed ID: 29046922
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack.
Cinci M; Mamidi S; Li W; Fehring V; Kirschfink M
Target Oncol; 2015 Sep; 10(3):405-13. PubMed ID: 25395366
[TBL] [Abstract][Full Text] [Related]
10. The effect of protein expression on cancer cell capture using the Human Transferrin Receptor (CD71) as an affinity ligand.
Lyons VJ; Helms A; Pappas D
Anal Chim Acta; 2019 Oct; 1076():154-161. PubMed ID: 31203960
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R
Thyroid; 2011 Mar; 21(3):267-77. PubMed ID: 21323588
[TBL] [Abstract][Full Text] [Related]
12. High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors.
Falvo E; Damiani V; Conti G; Boschi F; Messana K; Giacomini P; Milella M; De Laurenzi V; Morea V; Sala G; Fracasso G; Ceci P
J Exp Clin Cancer Res; 2021 Feb; 40(1):63. PubMed ID: 33568214
[TBL] [Abstract][Full Text] [Related]
13. The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
Kim YJ; Lee HS; Jung DE; Kim JM; Song SY
J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27891685
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Activity of Lipid-DNA Aptamer Modified T Lymphocytes in Carcinoma.
Zhong L; Gan L; Deng Z; Liu X; Peng H; Tang H; Liu X; Fang F; Yao F; Li W; Liu Z; Hou W; Cui C; Zhao Y; Tan W; Shi W; He J
J Biomed Nanotechnol; 2020 Jul; 16(7):1110-1118. PubMed ID: 33308378
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia.
Pande A; Dorwal P; Jain D; Tyagi N; Mehra S; Sachdev R; Raina V
Indian J Pathol Microbiol; 2016; 59(3):310-3. PubMed ID: 27510666
[TBL] [Abstract][Full Text] [Related]
16. Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.
Dong L; Tan Q; Ye W; Liu D; Chen H; Hu H; Wen D; Liu Y; Cao Y; Kang J; Fan J; Guo W; Wu W
Sci Rep; 2015 Oct; 5():15552. PubMed ID: 26497223
[TBL] [Abstract][Full Text] [Related]
17. Morphological definition of CD71 positive reticulocytes by various staining techniques and electron microscopy compared to reticulocytes detected by an automated hematology analyzer.
Kono M; Kondo T; Takagi Y; Wada A; Fujimoto K
Clin Chim Acta; 2009 Jun; 404(2):105-10. PubMed ID: 19302987
[TBL] [Abstract][Full Text] [Related]
18. CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.
Jia W; Ren C; Wang L; Zhu B; Jia W; Gao M; Zeng F; Zeng L; Xia X; Zhang X; Fu T; Li S; Du C; Jiang X; Chen Y; Tan W; Zhao Z; Liu W
Oncotarget; 2016 Aug; 7(34):55328-55342. PubMed ID: 27419372
[TBL] [Abstract][Full Text] [Related]
19. CD71 surface analysis of T cells: a simple alternative for extracorporeal photopheresis quality control.
Schwab L; Michel G; Bein G; Hackstein H
Vox Sang; 2020 Jan; 115(1):81-93. PubMed ID: 31680273
[TBL] [Abstract][Full Text] [Related]
20. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
